RIFLE Classification – Most Commonly Cited System
- Acute Rise in Cr Over 7 Days
- Risk of Renal Failure
- Increase in Serum Cr ≥ 1.5x Baseline
- Decrease in GFR ≥ 25% Baseline
- UOP < 0.5 cc/kg/hr for 6 Hours
- Injury of the Kidney
- Increase in Serum Cr ≥ 2.0x Baseline
- Decrease in GFR ≥ 50% Baseline
- UOP < 0.5 cc/kg/hr for 12 Hours
- Failure of the Kidney
- Increase in Serum Cr ≥ 3.0x Baseline or Cr ≥ 0.5 mg/dL if Bassline Cr ≥ 4 mg/dL
- Decrease in GFR ≥ 75% Baseline
- UOP < 0.3 cc/kg/hr for 24 Hours or Anuria for 12 Hours
- Loss of Kidney Function
- Complete Loss of Function ≥ 4 Weeks
- End-Stage Renal Disease
- Complete Loss of Function ≥ 3 Months
Acute Kidney Injury Network (AKIN) Classification
- Acute Rise in Cr Over 48 Hours
- Stage I
- Increase in Serum Cr ≥ 0.3 mg/dL
- Increase in Serum Cr ≥ 1.5x Baseline
- UOP < 0.5 cc/kg/hr for 6 Hours
- Stage II
- Increase in Serum Cr ≥ 2.0x Baseline
- UOP < 0.5 cc/kg/hr for 12 Hours
- Stage III
- Increase in Serum Cr ≥ 3.0x Baseline or Cr ≥ 0.5 mg/dL if Bassline Cr ≥ 4 mg/dL
- UOP < 0.3 cc/kg/hr for 24 Hours or Anuria for 12 Hours
- Initiation of Renal-Replacement Therapy (RRT)
Kidney Disease Improving Global Outcomes (KDIGO) Classification
- AKI Definition:
- Increase in Serum Cr ≥ 0.3 mg/dL within 48 Hours
- Increase in Serum Cr ≥ 1.5x Baseline within 7 Days
- UOP < 0.5 cc/kg/hr for 6 Hours
- Staging:
- Stage I
- Increase in Serum Cr ≥ 0.3 mg/dL
- Increase in Serum Cr ≥ 1.5x Baseline
- UOP < 0.5 cc/kg/hr for 6 Hours
- Stage II
- Increase in Serum Cr ≥ 2.0x Baseline
- UOP < 0.5 cc/kg/hr for 12 Hours
- Stage III
- Increase in Serum Cr ≥ 3.0x Baseline or Cr ≥ 4 mg/dL
- UOP < 0.3 cc/kg/hr for 24 Hours or Anuria for 12 Hours
- Initiation of Renal-Replacement Therapy (RRT)